MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer

Cancer

Volumn 118, Issue 13, 2012, Pages 3426-3432

  Vriens, Menno R ^a,b   Weng, Julie ^b   Suh, Insoo ^b   Huynh, Nhung ^b   Guerrero, Marlon A ^d   Shen, Wen T ^b   Duh, Quan Yang ^b   Clark, Orlo H ^b   Kebebew, Electron ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Biomarker; Cancer; Diagnostic; MicroRNA; Thyroid

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 125B; MICRORNA 138; MICRORNA 768 3P; TUMOR MARKER; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION BIOPSY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOCYTOMA; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; THYROID ADENOMA; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

CELL PROLIFERATION; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862530236     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26587     Document Type: Article

References (31)

1. Davies L, Welch HG,. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295: 2164-2167.
2. Visone R, Pallante P, Vecchione A, et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007; 26: 7590-7595. (Pubitemid 350207711)
3. Jazdzewski K, Liyanarachchi S, Swierniak M, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A. 2009; 106: 1502-1505.
4. Guo J, Miao Y, Xiao B, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009; 24: 652-657.
5. Chudova D, Wilde JI, Wang ET, et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab. 2010; 95: 5296-5304.
6. Kebebew E, Peng M, Reiff E, Duh Q-Y, Clark OH, McMillan A,. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms. World J Surg. 2006; 30: 767-774. (Pubitemid 43724104)
7. miRBase: the MicroRNA Database. Available at:. Accessed September 15, 2011.
8. Whitehead Institute for Biomedical Research. TargetScanHuman 5.2. Available at:. Accessed September 15, 2011.
9. PicTar. Available at:. Accessed September 15, 2011.
10. Nikiforova MN, Chiosea SI, Nikiforov YE,. MicroRNA expression profiles in thyroid tumors. Endocr Pathol. 2009; 20: 85-91.
11. Nam EJ, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008; 1: 14: 2690- 2695.
12. Yang H, Kong W, He L, et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008; 68: 425-433. (Pubitemid 351380068)
13. Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM,. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer. 2009; 48: 569-582.
14. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI,. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008; 14: 2588-2592.
15. Varnholt H, Drebber U, Schulze F, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology. 2008; 47: 1223-1232. (Pubitemid 351547908)
16. Pallante P, Visone R, Ferracin M, et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer. 2006; 13: 497-508. (Pubitemid 43886672)
17. Baffa R, Fassan M, Volinia S, et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol. 2009; 219: 214-221.
18. Yamada H, Yanagisawa K, Tokumaru S, et al. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer. Genes Chromosomes Cancer. 2008; 47: 810-818.
19. Ichimi T, Enokida H, Okuno Y, et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer. 2009; 125: 345-352.
20. Veerla S, Lindgren D, Kvist A, et al. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer. 2009; 124: 2236-2242.
21. Ozen M, Creighton CJ, Ozdemir M, Ittmann M,. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008; 27: 1788-1793. (Pubitemid 351380263)
22. He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005; 102: 19075-19080. (Pubitemid 43049568)
23. Mitomo S, Maesawa C, Ogasawara S, et al. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci. 2008; 99: 280-286. (Pubitemid 351228481)
24. Leite KR, Sousa-Canavez JM, Reis ST, et al. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol. 2011; 29: 265-269.
25. Visone R, Russo L, Pallante P, et al. MicroRNAs (miR) -221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer. 2007; 14: 791-798. (Pubitemid 350074067)
26. Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW,. Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res. 2009; 41: 482-487.
27. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C,. A limited set of human microRNA is deregulated in follicur thyroid cancer. J Clin Endocrinol Metab. 2006; 91: 3584-3591. (Pubitemid 44402141)
28. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA,. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003; 63: 1454-1457. (Pubitemid 36373628)
29. Kebebew E, Weng J, Bauer J, et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg. 2007; 246: 466-471.
30. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE,. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab. 2008; 93: 1600-1608. (Pubitemid 351656494)
31. Aherne ST, Smyth PC, Flavin RJ, et al. Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling. Mol Cancer. 2008; 7: 89.